"A New Era Is Beginning"

Steve Jobs: "The biggest innovations of the 21st century will be..." [Shield] AN OXFORD CLUB PUBLICATION [Wealthy Retirement]( [View in browser]( SPONSORED [**URGENT AI BIOTECH EVENT**]( In the coming days, an AI biotech - currently trading for less than $10 - is expected to make a bombshell announcement. And I do mean BOMBSHELL. These announcements have historically been known to generate FAR more explosive gains than FDA approval... and in a MUCH shorter time... As much as 509% MORE gains in some cases. Companies that have made similar announcements have seen their shares positively SOAR. [Ambrx Biopharma]( [And on June 27 at 2 p.m. ET]( America's #1 stock catalyst expert wants to give you all the details. Including why this coming announcement could be bigger and more important than anything we've seen in a lifetime. [Claim a free spot to attend right here.]( Editor's Note: A couple of months ago, Chief Income Strategist Marc Lichtenfeld was researching biotech stocks that are involved with artificial intelligence, and he'd found one he was quite intrigued by... But then he found a different company that absolutely blew him away. He quickly sent out an email to several members of our team, writing that the company "[has potential to be an all-time great drug company]( Tomorrow at 2 p.m. ET, Marc will host an urgent live broadcast to share more details on how an upcoming announcement from this company could spark an "[AI Biotech Revolution]( This could be your last chance to register for this free event... [Click here to claim your spot now!]( - James Ogletree, Managing Editor [MARKET TRENDS]( ["A New Era Is Beginning"]( [Marc Lichtenfeld, Chief Income Strategist, The Oxford Club]( [Marc Lichtenfeld]( Steve Jobs predicted, "The biggest innovations of the 21st century will be at the intersection of biology and technology. A new era is beginning." And we're starting to see that happen. As I told you on Saturday, some experts predict that by 2040, generative AI could result in $1 trillion in value for healthcare. Nvidia CEO Jensen Huang said it will be "the next amazing revolution [and] one of the biggest ever." Those are powerful words coming from someone like him. But let me be clear... This isn't just biotech 2.0. This revolution is so huge and so radical that scientists have come up with an entirely new word for it... TechBio. It's more than just a buzzword. It's a true paradigm shift. Biotech typically starts with the biological elements - living organisms, biological molecules, genetic material, etc. - and then applies data analysis, engineering principles and technology to manipulate or harness those biological components for desired products or outcomes. TechBio, on the other hand, often begins from an engineering, data science or technological standpoint. It leverages tools, devices, computational power and technologies first and then applies or integrates them with biological systems to study, measure or interface with those living systems. TechBio signifies a uniquely sophisticated method of drug development. And it can't be done without AI. SPONSORED [Yours Free! Top FIVE Dividend Stocks Right Now]( Marc Lichtenfeld - income expert and author of Get Rich with Dividends - is giving away his Ultimate Dividend Package... completely free of charge! You'll discover... - An "A"-rated, ultra-safe dividend stock with a huge 8% yield - Three of Marc's favorite "Extreme Dividend" stocks, which could supercharge your income - And finally, Marc's No. 1 dividend stock for a LIFETIME of income. [Click here to get the names and ticker symbols now](... before the download link expires. **NO CREDIT CARD REQUIRED!** Thanks to these innovations, we're starting to see how AI can accelerate the whole process of discovery and testing new compounds. It's taking a fraction of the time... in some cases making the process as much as 15 times faster. A study by Carnegie Mellon suggests AI could ultimately cut costs by as much as 70%. So AI is just the thing that will ignite a massive rally in these stocks. And soon. But that's not all... A Perfect Storm Is Brewing The cherry on top? Morgan Stanley analysts point out that a Fed rate cut will also fuel these stocks, writing, "In our view, there have been green shoots pointing to the beginnings of a rally in the biotech industry." All year, I've been saying rate cuts wouldn't come as quickly as most people expected, and I've been proven right. But one is coming eventually. And when that happens, look for this corner of the market to really take off. Why? Low rates provide a favorable financing environment and increase the valuations of biotech firms' pipelines, driving outperformance in the sector. Add it all up, and there's NEVER been a better time to jump into this market. Tomorrow at 2 p.m. ET, I'm hosting a special broadcast to discuss the unique way I plan on playing this situation for maximum potential gains. It's free to attend. [Go here to make sure your name is on my list!]( Good investing, Marc P.S. We're also offering a free gift for people who register for the event and sign up to be a VIP. Just [click here]( to register and claim your gift. [Leave a Comment]( [The Oxford Club's Wealth, Wine and Wander Tour with Marc Lichtenfeld in Munich, Salzburg, Vienna and Venice from December 1-10, 2024]( BUILD AND PROTECT YOUR WEALTH [New IPO Signs MAJOR Deal with Apple Until 2040. Will It Be the Next Trillion Dollar Company?]( [The Sweet Spot to Invest in the Biotech Sector]( [Discover the Top Passive Income Opportunity for 2024...]( [How Shareholders - Like You - are Public Benefactors]( MORE FROM WEALTHY RETIREMENT [Article]( [3 Trigger Events That Can Send Stocks Soaring]( [Article]( [The Top 2 Questions People Are Asking About AI]( [Article]( [Don't Give Wall Street Control of Your Portfolio]( [Article]( [Broadcom: A Semiconductor Superstar With a Safe Dividend]( [Facebook]( [Facebook]( [LinkedIn logo]( [LinkedIn]( [Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0AAI is poised to ignite a massive rally in this sector...%0D%0A%0D [Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0AAI is poised to ignite a massive rally in this sector...%0D%0A%0D [Push Alert]( [Push Alert]( SPONSORED [AI DIVIDENDS: No. 1 Way to Collect Passive Income]( Right now, a handful of AI companies are paying passive income to investors... And getting started couldn't be easier! To prove it, I'm giving you my Free AI Income Playbook (FREE OF CHARGE). [Click here to get it for free.]( [The Oxford Club]( You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Wealthy Retirement]( | [Unsubscribe]( © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [877.808.9795](#) | International: [+1.443.353.4621](#) [Oxfordclub.com]( Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.